Table 1 |
|||
|
Selected characteristics of enrolled subjects in this study |
|||
|
ATV/r (n = 21) |
LPV/r (n = 20) |
P value |
|
|
|
|||
|
Sex (M/F) |
21/0 |
20/0 |
|
|
Age: median, range (years) |
33.5, 21-45 |
35, 22-57 |
0.53 |
|
CD4 cell count at baseline: median, range (per μgL) |
132, 25-367 |
121, 18-340 |
0.37 |
|
Plasma HIV RNA at baseline: median, range (copies/mL) |
35200, 7500-232000 |
28900, 3500-356000 |
0.42 |
|
CD4 cell count at virological failure: median, range (per μgL) |
195, 37-468 |
202, 65-520 |
0.56 |
|
Plasma HIV RNA at virological failure: median, range (copies/mL) |
26500, 1500-87300 |
22500, 2200-67200 |
0.37 |
|
History of AIDS: no. (%) |
14 (67) |
15 (75) |
0.808 |
|
Experienced to NNRTI: no. (%) |
12 (57) |
13 (65) |
0.845 |
|
Duration of PI exposure: median, range (months) |
13.2, 4.8-18 |
11.3, 3.5-17 |
0.32 |
|
|
|||
|
Hsieh et al. BMC Infectious Diseases 2009 9:154 doi:10.1186/1471-2334-9-154 |
|||